Brief: Crispr Therapeutics Provides Business Update
May 8 (Reuters) - CRISPR Therapeutics AG CRSP.BN :
* CRISPR THERAPEUTICS PROVIDES BUSINESS UPDATE AND REPORTS
FIRST
QUARTER 2024 FINANCIAL RESULTS
Source text for Eikon: ID:nGNX7wRcBv
Further company coverage: CRSP.BN
Recent news on Crispr Therapeutics AG
See all newsBrief: CRISPR Therapeutics Announces Chief Financial Officer Transition
Swiss stocks - Factors to watch on August 4
Switzerland's CRISPR Therapeutics Q2 CASGEVY revenue jumps 151%, net loss narrows on FDA approval for expansion
Swiss stocks - Factors to watch on August 3
Gene-editing firm CRISPR steadies after boosted $550 mln convertible debt deal